![Sustained delivery of latanoprost by thermosensitive chitosan–gelatin-based hydrogel for controlling ocular hypertension - ScienceDirect Sustained delivery of latanoprost by thermosensitive chitosan–gelatin-based hydrogel for controlling ocular hypertension - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1742706114002438-fx1.jpg)
Sustained delivery of latanoprost by thermosensitive chitosan–gelatin-based hydrogel for controlling ocular hypertension - ScienceDirect
![Table 1 from Current Preferred Agents: BETAXOLOL, BRIMONIDINE (ALPHAGAN AND ALPHAGAN P), BRINZOLAMIDE (AZOPT), CARTEOLOL. DORZOLAMIDE/TIMOLOL, LATANOPROST, PILOCARPINE GEL AND DROPS, and TRAVOPROST (TRAVATAN Z®). Current Non-preferred Agents ... Table 1 from Current Preferred Agents: BETAXOLOL, BRIMONIDINE (ALPHAGAN AND ALPHAGAN P), BRINZOLAMIDE (AZOPT), CARTEOLOL. DORZOLAMIDE/TIMOLOL, LATANOPROST, PILOCARPINE GEL AND DROPS, and TRAVOPROST (TRAVATAN Z®). Current Non-preferred Agents ...](https://d3i71xaburhd42.cloudfront.net/98cdd2164fa796a85b0ddd1f2513fe8c855956dd/3-Table1-1.png)
Table 1 from Current Preferred Agents: BETAXOLOL, BRIMONIDINE (ALPHAGAN AND ALPHAGAN P), BRINZOLAMIDE (AZOPT), CARTEOLOL. DORZOLAMIDE/TIMOLOL, LATANOPROST, PILOCARPINE GEL AND DROPS, and TRAVOPROST (TRAVATAN Z®). Current Non-preferred Agents ...
![Development of optimized mucoadhesive thermosensitive pluronic based in situ gel for controlled delivery of Latanoprost: Antiglaucoma efficacy and stability approaches - ScienceDirect Development of optimized mucoadhesive thermosensitive pluronic based in situ gel for controlled delivery of Latanoprost: Antiglaucoma efficacy and stability approaches - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1773224719304897-fx1.jpg)
Development of optimized mucoadhesive thermosensitive pluronic based in situ gel for controlled delivery of Latanoprost: Antiglaucoma efficacy and stability approaches - ScienceDirect
![Full article: Preparation and characterization of latanoprost-loaded PVA nanofibers as an ocular drug delivery system for glaucoma treatment Full article: Preparation and characterization of latanoprost-loaded PVA nanofibers as an ocular drug delivery system for glaucoma treatment](https://www.tandfonline.com/action/showGraphicalAbstractImage?doi=10.1080%2F00914037.2023.2213387&type=img_lg&id=gpom_a_2213387_uf0001_c.jpeg)
Full article: Preparation and characterization of latanoprost-loaded PVA nanofibers as an ocular drug delivery system for glaucoma treatment
![Cumulative percent latanoprost released in Sorensen's phosphate buffer... | Download Scientific Diagram Cumulative percent latanoprost released in Sorensen's phosphate buffer... | Download Scientific Diagram](https://www.researchgate.net/publication/274458452/figure/fig4/AS:294703208648726@1447274129027/Cumulative-percent-latanoprost-released-in-Sorensens-phosphate-buffer-pH-74-containing.png)
Cumulative percent latanoprost released in Sorensen's phosphate buffer... | Download Scientific Diagram
![Preparation and performance of latanoprost-loaded hydrogels as a lacrimal suppository for the treatment of glaucoma - Siyu Xiao, Aijie Ma, Yanzhuo Ma, Haiyan Bai, Binghong Zhang, Juan Li, Hongwei Zhou, 2023 Preparation and performance of latanoprost-loaded hydrogels as a lacrimal suppository for the treatment of glaucoma - Siyu Xiao, Aijie Ma, Yanzhuo Ma, Haiyan Bai, Binghong Zhang, Juan Li, Hongwei Zhou, 2023](https://journals.sagepub.com/cms/10.1177/08853282221133181/asset/images/large/10.1177_08853282221133181-fig1.jpeg)